Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 398

1.

[Is there hope for hepatitis delta ?]

Guglielmi S, Frossard JL, Negro F.

Rev Med Suisse. 2016 Aug 31;12(528):1415-1418. French.

PMID:
28675280
2.

Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda.

Katwesigye E, Seremba E, Semitala F, Ocama P.

Afr Health Sci. 2016 Dec;16(4):1089-1093. doi: 10.4314/ahs.v16i4.26.

3.

Deep sequencing in the management of hepatitis virus infections.

Quer J, Rodríguez-Frias F, Gregori J, Tabernero D, Soria ME, García-Cehic D, Homs M, Bosch A, Pintó RM, Esteban JI, Domingo E, Perales C.

Virus Res. 2017 Jul 15;239:115-125. doi: 10.1016/j.virusres.2016.12.020. Epub 2016 Dec 28. Review.

PMID:
28040474
4.

Complete nucleotide sequences and construction of full-length infectious cDNA clones of cucumber green mottle mosaic virus (CGMMV) in a versatile newly developed binary vector including both 35S and T7 promoters.

Park CH, Ju HK, Han JY, Park JS, Kim IH, Seo EY, Kim JK, Hammond J, Lim HS.

Virus Genes. 2017 Apr;53(2):286-299. doi: 10.1007/s11262-016-1415-x. Epub 2016 Dec 2.

PMID:
27913980
5.

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity.

Shimura S, Watashi K, Fukano K, Peel M, Sluder A, Kawai F, Iwamoto M, Tsukuda S, Takeuchi JS, Miyake T, Sugiyama M, Ogasawara Y, Park SY, Tanaka Y, Kusuhara H, Mizokami M, Sureau C, Wakita T.

J Hepatol. 2017 Apr;66(4):685-692. doi: 10.1016/j.jhep.2016.11.009. Epub 2016 Nov 25.

PMID:
27890789
6.

Performance Characteristics of a New Consensus Commercial Kit for Hepatitis D Virus RNA Viral Load Quantification.

Le Gal F, Dziri S, Gerber A, Alloui C, Ben Abdesselam Z, Roulot D, Brichler S, Gordien E.

J Clin Microbiol. 2017 Feb;55(2):431-441. doi: 10.1128/JCM.02027-16. Epub 2016 Nov 23.

7.

A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa.

Amougou MA, Noah DN, Moundipa PF, Pineau P, Njouom R.

BMC Infect Dis. 2016 Nov 7;16(1):647.

8.

Hepatitis delta infection in Italian patients: towards the end of the story?

Stroffolini T, Sagnelli E, Sagnelli C, Russello M, De Luca M, Rosina F, Cacopardo B, Brancaccio G, Furlan C, Gaeta GB, Licata A, Almasio PL; behalf of EPACRON study group.

Infection. 2017 Jun;45(3):277-281. doi: 10.1007/s15010-016-0956-1. Epub 2016 Nov 5.

PMID:
27817147
9.

Cellular and viral peptides bind multiple sites on the N-terminal domain of clathrin.

Muenzner J, Traub LM, Kelly BT, Graham SC.

Traffic. 2017 Jan;18(1):44-57. doi: 10.1111/tra.12457. Epub 2016 Dec 14.

10.

Noninvasive markers for staging fibrosis in chronic delta hepatitis.

Takyar V, Surana P, Kleiner DE, Wilkins K, Hoofnagle JH, Liang TJ, Heller T, Koh C.

Aliment Pharmacol Ther. 2017 Jan;45(1):127-138. doi: 10.1111/apt.13834. Epub 2016 Nov 4.

11.

Cellular Nuclear Export Factors TAP and Aly Are Required for HDAg-L-mediated Assembly of Hepatitis Delta Virus.

Huang HC, Lee CP, Liu HK, Chang MF, Lai YH, Lee YC, Huang C.

J Biol Chem. 2016 Dec 9;291(50):26226-26238. Epub 2016 Nov 2.

12.

The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells.

Schirdewahn T, Grabowski J, Owusu Sekyere S, Bremer B, Wranke A, Lunemann S, Schlaphoff V, Kirschner J, Hardtke S, Manns MP, Cornberg M, Wedemeyer H, Suneetha PV.

J Infect Dis. 2017 Jan 1;215(1):139-149. doi: 10.1093/infdis/jiw514. Epub 2016 Oct 31.

PMID:
27803174
13.

Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone.

Weger-Lucarelli J, Duggal NK, Bullard-Feibelman K, Veselinovic M, Romo H, Nguyen C, Rückert C, Brault AC, Bowen RA, Stenglein M, Geiss BJ, Ebel GD.

J Virol. 2016 Dec 16;91(1). pii: e01765-16. Print 2017 Jan 1. Erratum in: J Virol. 2017 Mar 29;91(8):.

14.

Antiviral therapy of hepatitis delta virus infection - progress and challenges towards cure.

Wranke A, Wedemeyer H.

Curr Opin Virol. 2016 Oct;20:112-118. doi: 10.1016/j.coviro.2016.10.002. Epub 2016 Oct 26. Review.

PMID:
27792905
15.

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes.

Verrier ER, Colpitts CC, Bach C, Heydmann L, Zona L, Xiao F, Thumann C, Crouchet E, Gaudin R, Sureau C, Cosset FL, McKeating JA, Pessaux P, Hoshida Y, Schuster C, Zeisel MB, Baumert TF.

Cell Rep. 2016 Oct 25;17(5):1357-1368. doi: 10.1016/j.celrep.2016.09.084.

16.

The hepatitis D satellite virus of hepatitis B virus: half-opening a new era to control viral infection?

Abeywickrama-Samarakoon N, Cortay JC, Dény P.

Curr Opin Infect Dis. 2016 Dec;29(6):645-653. Review.

PMID:
27753688
17.

Prokaryotic Expression, Purification and Immunogenicity in Rabbits of the Small Antigen of Hepatitis Delta Virus.

Tunitskaya VL, Eliseeva OV, Valuev-Elliston VT, Tyurina DA, Zakirova NF, Khomich OA, Kalis M, Latyshev OE, Starodubova ES, Ivanova ON, Kochetkov SN, Isaguliants MG, Ivanov AV.

Int J Mol Sci. 2016 Oct 20;17(10). pii: E1721.

18.

A Two-Metal-Ion-Mediated Conformational Switching Pathway for HDV Ribozyme Activation.

Lee TS, Radak BK, Harris ME, York DM.

ACS Catal. 2016;6(3):1853-1869. Epub 2016 Feb 1.

19.

HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes.

Alfaiate D, Lucifora J, Abeywickrama-Samarakoon N, Michelet M, Testoni B, Cortay JC, Sureau C, Zoulim F, Dény P, Durantel D.

Antiviral Res. 2016 Dec;136:19-31. doi: 10.1016/j.antiviral.2016.10.006. Epub 2016 Oct 19.

PMID:
27771387
20.

Antiviral treatment and liver-related complications in hepatitis delta.

Wranke A, Serrano BC, Heidrich B, Kirschner J, Bremer B, Lehmann P, Hardtke S, Deterding K, Port K, Westphal M, Manns MP, Cornberg M, Wedemeyer H.

Hepatology. 2017 Feb;65(2):414-425. doi: 10.1002/hep.28876. Epub 2016 Nov 30.

PMID:
27770553

Supplemental Content

Loading ...
Support Center